Although the mean administration period was just less than a month, histological changes were seen in expression of α-SMA in tumor stroma, as well as EMT or proliferation markers of cancer cells, suggesting that PFD administration might inhibit tumor-stroma interactions and tumor growth in the human body. The gene discussed is ACTA1; the disease is cancer.